IndraLab

Statements

STAMBPL1 bound to SESN2 inhibits peptide. 1 / 1

| 1

reach

"Inhibiting the interaction between STAMBPL1 and Sestrin2 thereby inactivating mTORC1 using a cell-permeable peptide could be a potential treatment approach for gastric and colorectal cancers [141]."

39482684

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

STAMBPL1 bound to SESN2 inhibits peptide. 1 / 1

INDRA sources:

Databases

Reading